• Special Interview

original artical

• A Preliminary Phase-2 Study with very High-Dose of Melatonin (1000 mg/day) in Untreatable Advanced Cancer Patients Already Progression on Previous Palliative Therapy with High-Dose Melatonin

review

• The Paradigm of T Cells in Shaping Tumor Microenvironment
• To Use or not to Use Anticoagulation in Patients with Advanced Malignancies? – This is the Question

case report

• Role of Cetuximab Re-introduction and Re-challenge in Later Lines of Treatment in Metastatic Colorectal Cancer: A Case Series